Home › Funds › Lion Point Capital, LP › EWTX

Lion Point Capital, LP position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Lion Point Capital, LP reported holding 9,100 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$370K, representing 1.77% of its reported portfolio and ranking #22 among its reported holdings. Lion Point Capital, LP has disclosed EWTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)9.10K sh
Reported value held$369.73K
Portfolio Weight1.77%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's EWTX position evolved

Lion Point Capital, LP first disclosed a stake in EWTX in Q4 2025 at 9,100 shares (US$226K). The position peaked in Q2 2026 at 9,100 shares, worth US$370K. Across 3 filings, Lion Point Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 9,100 shares valued at US$370K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 9.10K $225.82K New
Q1 2026 9.10K $286.65K Hold
Q2 2026 9.10K $369.73K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Lion Point Capital, LP held EWTX?

Lion Point Capital, LP has disclosed EWTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Lion Point Capital, LP's current position in EWTX?

As of Q2 2026, Lion Point Capital, LP holds 9.10K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $369.73K, representing 1.77% of its reported portfolio and ranking #22.

Has Lion Point Capital, LP been buying or selling EWTX?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in EWTX. The position peaked in Q2 2026 at 9.10K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.